KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Current Taxes (2016 - 2025)

BeOne Medicines (ONC) has disclosed Current Taxes for 10 consecutive years, with $41.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Taxes rose 60.53% to $41.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.6 million, a 60.53% increase, with the full-year FY2025 number at $41.6 million, up 60.53% from a year prior.
  • Current Taxes was $41.6 million for Q4 2025 at BeOne Medicines, up from $11.2 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $41.6 million in Q4 2025 to a low of $5.5 million in Q2 2025.
  • A 5-year average of $23.8 million and a median of $23.0 million in 2023 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: fell 11.88% in 2023, then soared 60.53% in 2025.
  • BeOne Medicines' Current Taxes stood at $21.4 million in 2021, then increased by 17.73% to $25.2 million in 2022, then decreased by 8.88% to $23.0 million in 2023, then grew by 12.98% to $25.9 million in 2024, then soared by 60.53% to $41.6 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Current Taxes are $41.6 million (Q4 2025), $11.2 million (Q3 2025), and $5.5 million (Q2 2025).